Article
Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine
25 May 2016
Abstract excerpt
Campylobacter jejuni is a predominant cause of human gastroenteritis worldwide. Source-attribution studies indicate that chickens are the main reservoir for infection, thus elimination of C. jejuni from poultry would significantly reduce the burden of human disease. We constructed glycoconjugate vaccines combining the conserved C. jejuni N-glycan with a protein carrier, GlycoTag, or fused to the Escherichia coli...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
